These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 7353082)

  • 1. Intravascular haemolysis and renal failure caused by intermittent rifampicin treatment.
    Criel A; Verwilghen RL
    Blut; 1980 Feb; 40(2):147-50. PubMed ID: 7353082
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rifampicin-associated acute renal failure: pathophysiologic, immunologic, and clinical features.
    De Vriese AS; Robbrecht DL; Vanholder RC; Vogelaers DP; Lameire NH
    Am J Kidney Dis; 1998 Jan; 31(1):108-15. PubMed ID: 9428460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Adverse effect of the intermittent use of rifampicin in treating Hansen's disease].
    Papaiordanou PM; Branchini ML; Gonçales Júnior FL; Aoki FH; Boccato RS; Ramos Mde C; Pedro RJ
    Rev Inst Med Trop Sao Paulo; 1988; 30(5):383-6. PubMed ID: 3249905
    [No Abstract]   [Full Text] [Related]  

  • 4. IgG-mediated intravascular hemolysis and nonoliguric acute renal failure complicating discontinuous rifampicin administration.
    Diamond JR; Tahan SR
    Nephron; 1984; 38(1):62-4. PubMed ID: 6472533
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Severe complications following intermittent administration of rifampicin].
    Manasia M; Paul G; Maniţiu PI
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1976; 25(3):183-8. PubMed ID: 188103
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Life-threatening, multiple hypersensitivity reactions induced by rifampicin in one patient with pulmonary tuberculosis.
    Luzzati R; Giacomazzi D; Franchi F; Barcobello M; Vento S
    South Med J; 2007 Aug; 100(8):854-6. PubMed ID: 17715477
    [No Abstract]   [Full Text] [Related]  

  • 7. [Immunoallergic complication induced by rifampicin with disseminated intravascular coagulation].
    Denis J; Robert A; Johanet C; Homberg JC; Opolon P; Levy VG
    Presse Med; 1983 May; 12(23):1479-81. PubMed ID: 6222344
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal failure during intermittent rifampicin therapy.
    Chan WC; O'Mahoney MG; Yu DY; Yu RY
    Tubercle; 1975 Sep; 56(3):191-8. PubMed ID: 129898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adverse reactions to rifampicin in antituberculosis regimens.
    Girling DJ
    J Antimicrob Chemother; 1977 Mar; 3(2):115-32. PubMed ID: 324964
    [No Abstract]   [Full Text] [Related]  

  • 10. Rifampicin-induced acute renal failure: a series of 60 patients.
    Covic A; Goldsmith DJ; Segall L; Stoicescu C; Lungu S; Volovat C; Covic M
    Nephrol Dial Transplant; 1998 Apr; 13(4):924-9. PubMed ID: 9568851
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mild haemolysis associated with flu-syndrome during daily rifampicin treatment--a case report.
    Yeo CT; Wang YT; Poh SC
    Singapore Med J; 1989 Apr; 30(2):215-6. PubMed ID: 2609182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A case of rifampicin-induced haemolysis.
    Sykes CA; Shepherd J; McGoldrick C; Kennedy N; Raafat A
    Int J Tuberc Lung Dis; 2019 Feb; 23(2):239-240. PubMed ID: 30808458
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Severe acute renal failure due to tubulointerstitial nephritis, pancreatitis, and hyperthyroidism in a patient during rifampicin therapy.
    Paydas S; Balal M; Karayaylali I; Seyrek N
    Adv Ther; 2005; 22(3):241-3. PubMed ID: 16236685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Acute intravascular haemolysis and renal failure due to teniposide related antibody.
    Habibi B; Baumelou A; Seradaru M
    Lancet; 1981 Jun; 1(8235):1423-4. PubMed ID: 6113378
    [No Abstract]   [Full Text] [Related]  

  • 15. Acute renal failure caused by rifampicin re-exposure with 10-year of interval.
    Tsai TL; Lee CH; Chuang FR; Hsu KT
    Chang Gung Med J; 2001 Nov; 24(11):729-33. PubMed ID: 11820654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [2 cases of hemolytic complications during intermittent treatment with rifampicin].
    Năstase M; Brener E; Năstase R; Borgovan L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1975; 24(1):43-6. PubMed ID: 171722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular hemolysis and acute renal failure following intermittent rifampin therapy.
    Gupta A; Sakhuja V; Gupta KL; Chugh KS
    Int J Lepr Other Mycobact Dis; 1992 Jun; 60(2):185-8. PubMed ID: 1522360
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A case of acute renal failure after intermittent rifampicin therapy].
    Fukunishi Y; Imaizumi M; Imagawa A; Yamashita T
    Nihon Rai Gakkai Zasshi; 1984; 53(4):193-9. PubMed ID: 6536642
    [No Abstract]   [Full Text] [Related]  

  • 19. Potentially serious side effects of high-dose twice-weekly rifampicin.
    Poole G; Stradling P; Worlledge S
    Br Med J; 1971 Aug; 3(5770):343-7. PubMed ID: 5314737
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acute renal failure after rifampicin: a case report and survey of the literature.
    Nessi R; Bonoldi GL; Redaelli B; di Filippo G
    Nephron; 1976; 16(2):148-59. PubMed ID: 1105220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.